Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
German Medical Science GMS Publishing House
2013-11-01
|
Series: | GMS Infectious Diseases |
Online Access: | http://www.egms.de/static/en/journals/id/2013-1/id000007.shtml |
ISSN: | 2195-8831 |
---|